Cytokeratin-19 as a biomarker in urine and in serum for the diagnosis of endometriosis--a prospective study

Lorenz Kuessel, Jaeger-Lansky A, Agnes Jaeger-Lansky, Petra Pateisky, Pateisky P, Nora Rossberg, Rossberg N, Schulz A, Anke Schulz, Arndt A P Schmitz, Arndt A. Schmitz, Christine Staudigl, Staudigl C, René Wenzl, Wenzl R
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2013 · vol. 30(1) , pp. 38–41 · doi:10.3109/09513590.2013.856409 · PMID:24219598 · W2089646129
Non-randomised trial OA: closed CC0 ⤵ 19 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study investigated Cytokeratin-19 in urine and serum for endometriosis diagnosis but found no statistically significant correlation between CK19 concentrations and endometriosis presence in a larger sample size.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis compromises the quality of life of countless women worldwide and is a leading cause of disability. Clinical symptoms of endometriosis can be very heterogeneous leading to a long interval between onset of symptoms and surgical diagnosis. A noninvasive, rapid diagnostic test is urgently needed. In this prospective study, we evaluated the usefulness of Cytokeratin-19 (CK19) as a biomarker for the diagnosis of endometriosis through urine and serum ELISA. 76 reproductive-aged women undergoing laparoscopy for benign conditions were included to this study and divided into two groups by the presence (n = 44) or absence (n = 32) of endometriosis. There was no statistically significant correlation between the concentration of CK19 in urine (p = 0.51) or in serum (p = 0.77) and the diagnosis of endometriosis. Assigning the samples to the proliferative or secretory cycle stage did not sufficiently lower the p values. In this study, the promising data reported in the recent literature about CK19 serving as a sufficient biomarker for endometriosis could not be verified when tested in a larger sample size. Further studies are warranted to explore the usefulness of CK19 in the diagnosis of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Biomarkers Biomarkers Endometriosis Keratin-19 Keratin-19 Peritoneal Diseases Adult Adult Biomarkers Biomarkers Case-Control Studies Case-Control Studies Endometriosis Endometriosis Endometriosis Endometriosis Female Female Humans Humans

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (23)

Cited by (19)

Source provenance

europepmc
last seen: 2026-10-26T06:15:05.866214+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:12:48.765018+00:00
unpaywall
last seen: 2026-10-26T06:31:53.434635+00:00
License: CC0 · commercial use OK